V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 2.53 USD Market Closed
Market Cap: 70.4m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

Wall Street
Price Targets

VTGN Price Targets Summary
VistaGen Therapeutics Inc

Wall Street analysts forecast VTGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTGN is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

Lowest
Price Target
12.12 USD
379% Upside
Average
Price Target
13.77 USD
444% Upside
Highest
Price Target
15.75 USD
523% Upside
VistaGen Therapeutics Inc Competitors:
Price Targets
MRNA
Moderna Inc
91% Upside
2616
CStone Pharmaceuticals
31% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
27% Upside
GILD
Gilead Sciences Inc
8% Upside
1952
Everest Medicines Ltd
21% Downside
AKBA
Akebia Therapeutics Inc
198% Upside
BIOCON
Biocon Ltd
4% Upside
300685
Amoy Diagnostics Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
VistaGen Therapeutics Inc

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 3 years is 89%.

N/A
Past Growth
89%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
VistaGen Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-76%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTGN's stock price target?
Price Target
13.77 USD

According to Wall Street analysts, the average 1-year price target for VTGN is 13.77 USD with a low forecast of 12.12 USD and a high forecast of 15.75 USD.

What is VistaGen Therapeutics Inc's Revenue forecast?
Projected CAGR
89%

The compound annual growth rate of VistaGen Therapeutics Inc's revenue for the next 3 years is 89%.

Back to Top